Session 6
Hyperthermia drug delivery, Nanoparticles, Emerging applications

Programme

• 13:30 – 13:48 15 Min. 3 Min.

  Targeted Tumor Therapy enhanced by Hyperthermia

  • Prof. Dr. Lars H. Lindner (Munich, DE)
• 13:48 – 14:00 10 Min. 2 Min.

  Targeted Magneto-liposomes for Magnetic Hyperthermia Therapy mediated Chemo-Radiosensitization in solid tumors: Role of HSP90 and Ferroptosis

  • Dr. Neena Shetake (Mumbai, IN)

   Hyperthermia Drug Delivery, Nanoparticles
• 14:00 – 14:12 10 Min. 2 Min.

  Local delivery of cisplatin using thermosensitive liposomes and MR-HIFU hyperthermia in a large animal model

  • Dr. Lukas Sebeke (Cologne, DE)

   Hyperthermia Drug Delivery, Nanoparticles
• 14:12 – 14:24 10 Min. 2 Min.

  Treating solid tumors in-vivo with stereotactic radiation (SBRT) and hyperthermia

  • Mr. Folefac Charlemagne Asonganyi (AARHUS, DK)

   Hyperthermia Drug Delivery, Nanoparticles
• 14:24 – 14:36 10 Min. 2 Min.

  Targeting microRNAs involved in hyperthermia-induced radiosensitivity: The future in treatment of cervical cancer?

  • Dr. Barbara Snoek (Amsterdam, NL)

   Other
• 14:36 – 14:48 10 Min. 2 Min.

  A heat-activated drug-delivery platform: enhancing drug delivery with nanocarriers based on Phosphatidyl-(Oligo)-Glycerol

  • Bettina Heiß (München, DE)

   Hyperthermia Drug Delivery, Nanoparticles
• 14:48 – 15:00 10 Min. 2 Min.

  Systemic treatment with iron oxide nanoparticles inhibits the progression of metastatic cancer by altering the host immune profile in mouse models of breast cancer

  • Dr. Preethi Korangath (Baltimore, US)

   Hyperthermia Drug Delivery, Nanoparticles